Clinical Trial Update: Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction [Phase 3]

View source ↗

Summary

A Phase 3 randomized interventional trial evaluating initiation of spironolactone in heart failure with preserved ejection fraction is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: Uppsala University | Conditions: Heart Failure With Preserved Ejection Fraction | Phase 3 | Status: RECRUITING